EUFEPSFourth European Congress of

Pharmaceutical Sciences

Milan, Italy, September 11-13, 1998
SISF
Milan

CALL FOR CONTRIBUTED PAPERS

Scientific contributions are welcomed from anywhere in the world on any topics covered by the EUFEPS '98 Congress. All abstracts will be rapidly considered by the Scientific Programme Committee, which will allocate papers for oral or poster presentation. Please send Abstracts (original plus 3 photocopies) as hard copies. Please note that abstracts sent by fax or e-mail cannot be accepted, unless backed up by original hard copies sent by express mail. The deadline for submission of abstracts is April 20, 1998.

Abstract Format
Abstracts should be formatted on white paper inside a box with the following dimensions: 115 mm wide x 155 mm high. The abstract must be written in English, following the format indicated in the Instructions for Preparing Abstracts.

Confirmation of receipt of the Abstract
A letter of acknowledgment will be sent to the presenting author upon receipt of each Abstract.

Letter of acceptance
The official letter of acceptance, including guidelines for presentation (slide facilities for Oral presentations, or details of Poster format), will be sent to the presenting author by mid-May.

Late-breaking Abstracts
Subject to the availability of space, Abstracts on late-breaking research work submitted after April 20, 1998 will be rapidly considered for poster presentation. Although these will not be published in the Abstract Book, a copy of these abstracts will be distributed to participants. Please contact the EUFEPS '98 Organizing Secretariat for further details.

Abstract Book
Accepted Abstracts received by the deadline will be published in a supplement of the European Journal of Pharmaceutical Sciences (Elsevier Science), with an official ISSN abstracted by all the major abstracting agencies. This is the Official Journal of the European Federation for Pharmaceutical Sciences. All participants will receive the Abstract Book with the Final Programme at the Congress itself.

New EUFEPS Awards
Details of the new EUFEPS  Young Investigator Awards presented in Milan for outstanding research achievements in Poster Presentation can be found in the General Information section.

The Segre Award in Pharmacokinetics/Pharmacodynamics will be presented for the first time at EUFEPS '98 in Milan. Further details can be found in the General Information section.

milan

 

LIST OF TOPICS FOR WORKSHOPS, SELECTED ORAL COMMUNICATIONS AND POSTERS

A. STRATEGIES AND TECHNOLOGIES IN DRUG DISCOVERY

A1. New Processes in Drug Discovery

A2. New Targets for Novel Drugs

A3. Discovery and Development of Novel Natural Products

A4. Site-Specific Drug Delivery

A5. Vectors for Gene Therapy

 

B. STRATEGIES AND TECHNOLOGIES IN DRUG DEVELOPMENT

B1. Dosage Form Design: Clinical Issues

B2. Drug Delivery Systems

B3. Powder Technology, Science of Materials and Engineering

B4. Peptide and Protein Drugs

B5. Parenteral Drug Development

B6. Development of Generics

B7. Biodisposition and Bioequivalence

B8. Pharmacokinetics/Pharmacodynamics and Biotransformation in Drug Development

B9. Cell and Tissue Culture in Pharmaceutical Development

B10. Chemical Development: Current Issues

B11. Advances in Analytical Technologies

 

C. STRATEGIES FOR SELECTIVITY IN DISEASE TREATMENT AND PREVENTION

C1. Therapeutic and Pharmaceutical Advances in the Treatment of Chronic Diseases

C2. Drugs and AIDS

C3. Drugs and Alzheimer's Disease

C4. Drugs and Atherosclerosis

C5. Drugs and Cancer

C6. Drugs and Neurodegenerative Diseases

C7. Oxidative Damage and Radical Formation Antagonists

 

D. TRENDS IN DRUG RESEARCH

D1. Biotechnology Drug Development and Characterization

D2. New Vaccines

D3. New Approaches Against Drug Resistance

D4. Generics in the Global Pharmaceutical Market

D5. Research and Regulatory Issues in Clinical Pharmacy

INSTRUCTIONS FOR PREPARING ABSTRACTS

An abstract form is available as an Adobe Acrobat (PDF) file. You must either download the Adobe Acrobat PDF Viewer plug-in or Adobe Acrobat Reader in order to view this file. You can download the Acrobat Reader for free at the Adobe website.

1. White paper should be used with a box of the following dimensions: 115 mm wide x 155 mm high. Single space all typing on the form. Abstracts must be submitted in English. The text of the abstract should be a single paragraph starting with a 3-space indentation. Leave 1 space between last line of address(es) and first line of text. Leave no top or left margin within the box. Use short specific titles. Use standard abbreviations. Give the title in bold uppercase characters. Capitalize the first letter of trade names. Please type the abstract using a point size of preferably 11 or 12 (in any case not smaller than 10). Please type within the dimensions of the box as noted above.

2. Your abstract must include a concise, descriptive title, author(s), location where work was done, text and acknowledgments.

3. Your abstract should be of the informative type, containing: (a) a short statement of the study's specific objectives, unless this is given by the title; (b) a brief statement of methods, if pertinent; (c) a summary of the results obtained; (d) a statement of the conclusions. It is NOT acceptable to state: "The results will be discussed".

4. When using abbreviations for compounds, spell them out in full when first mentioned, followed by the abbreviation in parentheses (see sample abstract). Do not abbreviate compounds in the title of the abstract.

5. Spell out any Greek letter in the title. Avoid superscripts and subscripts in the title. Any hand-written symbols must be drawn in black ink. Tables are permitted within the abstract text.

6. Underline only the name of the author who will actually present the paper. Unless otherwise stated, it is assumed that the first named author will be the presenter. The presenting author will receive all future correspondence.

7. Please remember that your abstract will appear in a 70% reduced form in the Abstract Book exactly as you submit it. Any erasure smudges, errors, misspellings, poor hyphenations and deviations from good usage will be glaringly apparent in the published abstract. If a mistake is made in typing, type the corrected word on another sheet of paper and very carefully glue over the incorrect word with rubber cement.

8. The original typed copy of your abstract form (for reduced reproduction by photo-offset in the Abstract Book) must be submitted together with 3 photocopies. Abstracts sent by fax and by e-mail will NOT be accepted, unless the original is sent by express mail.

9. Please note: Resubmission of an abstract to make corrections or changes is not possible.

10. Any question concerning your abstract should be referred to the EUFEPS '98 Secretariat:

EUFEPS '98
FONDAZIONE GIOVANNI LORENZINI MEDICAL SCIENCE FOUNDATION
Via Appiani, 7 - 20121 Milan (Italy)
Phone: +39-2-29.00.62.67 - Telefax: +39-2-29.00.70.18

 

SAMPLE ABSTRACT TO SHOW STYLE

 

THE PHARMACOLOGY OF LEUKOTRIENE C4 IN ISOLATED GUINEA-PIG LUNGS
G.C. Folco, C. Omini, G. Brunelli, T. Viganò and F. Berti
Institute of Pharmacology and Pharmacognosy, Via A. del Sarto, 21, 20129 Milan, Italy.

Leukotriene C4 (LTC-4) has been recently identified as an important component of slow reacting substance of anaphylaxis (SRS-A) and considerable work is now in progress to elucidate its physiological role. Since SRS-A has been known to play a major role in a number of immediate hypersensitivity reactions and in anaphylaxis, we decided to investigate the cardiopulmonary potential of LTC-4 with special attention to its capacity to trigger formation of other arachidonic acid (AA) metabolites................................

 

ABSTRACT FORM to be sent as hard copy by April 20, 1998 to:

EUFEPS '98
FONDAZIONE GIOVANNI LORENZINI
MEDICAL SCIENCE FOUNDATION
Via Appiani, 7 - 20121 Milan (Italy)

 

 
*Front Page*General Information*Registration
*Accommodation*Scientific Programme*Social Programme